Exacerbation of COVID 19 in Hypertensive Patients
الباحثونNoor H. Naser، Ammar Abdul Aziz Alibeg
المجلةIraqi J Pharm Sci
مختصر البحثAbstract
Since its discovery in December 2019, corona virus was outbreak worldwide with a very rapid rate, so it described by World Health Organization (WHO) as a pandemic. It associated with severe acute respiratory distress syndrome, and can invade the cells through Angiotensin Converting Enzyme 2 (ACE 2) receptor which play an important role as regulator for blood pressure. Hypertension is a potential risk factor for sever acute respiratory syndrome COVID-19, and associated with high mortality rate as shown in many epidemiological studies. A lot of published article reviews, retrospective and meta-analysis regard the association between COVID-19 and hypertension. Moreover, specific antihypertensive medications that infected patients were receiving are not known; only data about renin-angiotensin-aldosterone system (RAAS) are available.
Objective: To summarize the most updated data of COVID-19 in hypertensive patients.
Keywords: COVID-19, hypertension, Angiotensin Converting Enzyme 2 (ACE2)
Evaluation of the Mixture of phoenix Dactylifera Seeds extract and Chalcone Derivativeas Anti-Angiogenic Agents in Ex-Vivo Rat Aorta Ring Model
الباحثونSamer Ali Hasan1، Ammar Abdul Aziz Alibeg2, Zeena Ayad Hussein3
المجلةAnnals of R.S.C.B
مختصر البحثAbstract:
Angiogenesis is very important in the progression of various pathological disorders, most importantly tumor growth and metastasis. This research aims to investigate the efficacy of the synthetic chalcone derivative)2-Hydroxychalcone)and its mixture with ethanolic extract of Phoenix dactylifera seeds as anti-angiogenic agents. The synthetic chalcone derivative was synthesized according to Claisen-Schmidt condensation method using SOCl2/ETOH as a catalyst with a good yield. The structure of the synthesizedchalcone derivative has been characterized by TLC, melting point, UV, and IR Spectroscopy , and elemental microanalysis (CHNO). The powdered seeds of P. dactylifera were extracted by soxhlet extraction with Ethanol. The synthetic chalcone derivative alone at concentration (17.15μg/ml) and its mixture with ethanolicextract of P. dactylifera seeds were evaluated for its anti-angiogenic activity using the ex-vivo rat aorta ring model at concentrations 17.15μg/ml and 30.9μg/ml respectively. At the previously mentioned concentrations, The synthetic chalcone derivativewas able to inhibit growth of blood vessels significantly (56.23%) in rat aorta ring assay in comparison with the negative control (P<0.05), while the mixture of the synthetic chalcone derivative and ethanolic extract of P. dactylifera seeds showed higher percentage of inhibition (76.63%)than that of the synthetic chalcone derivative alone in comparison with the negative control (P<0.05).Thisproduced effect could be due to the synergism between the synthetic chalcone derivative and the phytochemical constituents present in ethanolic extract in inhibiting different angiogenesis signaling pathways.
Design, Synthesis, and Antibacterial Study of New Gatifloxacin-Antioxidants
as Mutual Prodrugs
الباحثونNoor H. Nasser، Sahar A. Hussein, Ahmed K. Hussein, Ammar A. Alibeg, and Zainab M.
Jasim
المجلةJ Biochem Tech
مختصر البحثAbstract
Objective: The objective of this search is to design, and
synthesize new mutual prodrugs in order to obtain synergistic
antibacterial activity. Methods: The hydroxyl group of three
antioxidants (menthol, thymol, and vanillin), was linked to
chloroacetyl chloride through nucleophilic substitution reaction,
to give intermediates (Ia-Ic), which were reacted with a carboxyl
group of Gatifloxacin to form three final compounds (I-III)
having ester linkage. Results: The Antibacterial activity effect of
the target compounds (I-III) has been tested for in vitro inhibitory
activity against Gram-positive bacteria: Staphylococcus aureus
and Gram-negative bacteria: Escherichia coli by using spots
diffusion method. All the tested compounds show a remarkable
antibacterial activity against tested bacteria. Conclusion: The
synthesized prodrugs were characterized and identified through
FT-IR spectroscopy, 1H-NMR spectrum, and various
physicochemical parameters. The antibacterial study of the
compounds showed various activities toward the two types of
pathogenic bacteria which are Staphylococcus aureus and
Escherichia coli. Compounds [I, II, and III] revealed that
Staphylococcus aureus was sensitive to synthesized compounds
but Escherichia coli showed a reverse activity with some
resistance for antibacterial drugs .
Design and Synthesis of Possible Mutual Prodrugs of
(Nsaid) Etodolac and Tolmetin with (Cytotoxic)
Gemcitabine
الباحثونAmmar Abdul Aziz Alibeg1، Abbas H. Abdulsada2, Noor H. Nasser3, Karrar Abdil Aziz Ali beg4
المجلةSys Rev Pharm
مختصر البحثABSTRACT
[NSAIDs] Non-steroidal anti-inflammatory drugs consider an important group of
drugs due to their properties as anti-inflammatory and it have both antipyretic
and pain killer activities. [COX-II] plays an important role all over oncogenesis and
here we attempt the same thing to search the use of [NSAID] (Etodolac &
tolmetin) in conjugation with current cytotoxic agent (Gemcitabine) for the
prevention and/or management of cancer. This study distinguishes the designing
and synthesis of mutual prodrug of [NSAID] & gemcitabine, which is specified to
create the concomitantly pharmacological action as a one chemical entity with
amend of targeting of drug. The synthesized compound was conferred by TLC,
CHNS, FTIR and physicochemical properties. The newly synthesized prodrug is
predicted to reduce the adverse effects of [NSAIDs] on the (GIT) gastrointestinal
tract with enhancement of gemcitabine oral bioavailability and its targeting.
Design, Synthesis and Preliminary Pharmacological Evaluation of Mutual Prodrug of Non Steroidal Anti-Inflammatory Drugs Coupling with Natural Anti-Oxidants
الباحثونAMMAR ABDUL AZIZ ALIBEG1، SAMER A. HASAN2, AHMAD K. HUSSEIN3, NOOR H. NASSER4, KARRAR ABDIL AZIZ ALIBEG
المجلةInternational Journal of Pharmaceutical Research
مختصر البحثABSTRACT
Non steroidalanti inflammatory drugs NSAIDs Etodolac and tolmetin drugs have been coupled with varies natural antioxidants having antiulcerogenicpropertiesin order to get mutual prodrug consist of NSAIDs & antioxidant as a safer NSAIDs withoutgastrointestinal side-effects. The designated pro-drugs are well studied to explain their anti inflammatory, anti ulcer and analgesic activity. The mutual prodrug shows the same activity as anti inflammatory with decrease ulcerogenecity. The study results show that the mutual prodrug of NSAIDs antioxidant has the strength to create new NSAIDs with decreased undesirable adverse effects.
Design and Synthesis of Possible Mutual Prodrugs of Naproxen
and Acetylsalicylic Acid with Gemcitabine
الباحثونAmmar Abdul Aziz Alibeg
المجلةJournal of Applicable Chemistry
مختصر البحثABSTRACT
‘Non-steroidal anti-inflammatory’ (NSAIDs) drugs are most commonly used type of medications and its
long period of use result in unwanted side effect like (GI) ulceration. (COX-II) have an important role all
over oncogenesis and so I explain the cause of using (NSAID) (naproxen and Acetylsalicylic acid) together
with cytotoxic drug [Gemcitabine] in the management of cancer. The research outlines the designing and
synthesis of mutual prodrug of (NSAID) and (gemcitabine), which is nominated to create the
interdependent pharmacological action as a single pharmacological unit with enhanced drug targeting.
The synthesized products was advised by (FTIR) chart, (CHNS) analysis and physiochemical properties.
The synthesized prodrug is supposed to diminish the undesirable effect of (NSAIDs) on the (GI) tract with
amendment of the bioavailability and cancer targeting for (gemcitabine).